Endoprotech
1 known investors
Endoprotech develops anti-inflammatory liposome therapeutics that modify cell plasma membranes to address microvascular dysfunction, with a focus on reducing injury and recovery time in cardiac conditions.
BiotechDeep TechMedical Devices